ADAR1 Capital Management, LLC Q4 2024 Filing
Filed February 13, 2025
Portfolio Value
$500.4B
Holdings
206
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (206 positions)
| Stock | Value |
|---|---|
PTGXPROTAGONIST THERAPEUTICS INC | $44.5B |
ROIVROIVANT SCIENCES LTD | $41.5B |
BOXXEA SERIES TRUST | $35.9B |
ZLABZAI LAB LTD | $27.4B |
CYTKCYTOKINETICS INC | $20.2B |
IMVTIMMUNOVANT INC | $19.5B |
BBIOBRIDGEBIO PHARMA INC | $18.6B |
IKTINHIBIKASE THERAPEUTICS INC | $16.6B |
BILSPDR SER TR | $12.0B |
ABVXABIVAX SA | $11.1B |
MLYSMINERALYS THERAPEUTICS INC | $10.4B |
ASNDASCENDIS PHARMA A/S | $9.8B |
—PERCEPTIVE CAP SOLUTIONS COR | $7.6B |
RVMDREVOLUTION MEDICINES INC | $7.4B |
RZLTREZOLUTE INC | $6.7B |
0C3ENDEAVOR GROUP HLDGS INC | $6.6B |
CGONCG ONCOLOGY INC | $6.2B |
AVRANTERIS TECHNOLOGIES GLOBAL | $5.9B |
YCYAA MISSION ACQUISITION CORP | $5.7B |
—COHERUS BIOSCIENCES INC | $5.5B |
XNCRXENCOR INC | $5.4B |
ZURAZURA BIO LTD | $5.2B |
I9DNARBUTUS BIOPHARMA CORP | $5.1B |
OACCOAKTREE ACQUISITION CORP III | $5.1B |
SRPTSAREPTA THERAPEUTICS INC | $4.9B |
SNYSANOFI | $4.8B |
XBISPDR SER TR | $4.5B |
GOSS 5 06/01/27GOSSAMER BIO INC | $4.4B |
HLXCHELIX ACQUISITION CORP II | $4.2B |
ETNBGBP89BIO INC | $4.0B |
BBIO 2.25 02/01/29BRIDGEBIO PHARMA INC | $3.9B |
MRUSMERUS N V | $3.4B |
KNSAKINIKSA PHARMACEUTICALS INTL | $3.3B |
ALDXALDEYRA THERAPEUTICS INC | $3.2B |
TEVATEVA PHARMACEUTICAL INDS LTD | $3.2B |
YB4PSAVARA INC | $3.0B |
GRCEGRACE THERAPEUTICS INC | $2.9B |
MNPRMONOPAR THERAPEUTICS INC | $2.9B |
CRNXCRINETICS PHARMACEUTICALS IN | $2.7B |
TECXTECTONIC THERAPEUTIC INC | $2.7B |
RCKTROCKET PHARMACEUTICALS INC | $2.7B |
CNTACENTESSA PHARMACEUTICALS PLC | $2.6B |
AVTEAEROVATE THERAPEUTICS INC | $2.5B |
KRROKORRO BIO INC | $2.2B |
PTCTPTC THERAPEUTICS INC | $2.2B |
ASPCRA SPAC III ACQUISITION CORP | $2.2B |
BBIO 2.5 03/15/27BRIDGEBIO PHARMA INC | $2.1B |
CAPRCAPRICOR THERAPEUTICS INC | $2.1B |
XENEXENON PHARMACEUTICALS INC | $2.0B |
APGEAPOGEE THERAPEUTICS INC | $1.9B |
RAPTEURRAPT THERAPEUTICS INC | $1.9B |
DCTHDELCATH SYS INC | $1.8B |
PLRXPLIANT THERAPEUTICS INC | $1.8B |
PVLAPALVELLA THERAPEUTICS INC NE | $1.7B |
RYTMRHYTHM PHARMACEUTICALS INC | $1.7B |
JANXJANUX THERAPEUTICS INC | $1.7B |
AXSMAXSOME THERAPEUTICS INC | $1.7B |
SLNOSOLENO THERAPEUTICS INC | $1.7B |
KALAKALA BIO INC | $1.5B |
—ARES ACQUISITION CORP II | $1.5B |
IM8NINSMED INC | $1.5B |
PPHMEURAVID BIOSERVICES INC | $1.5B |
RGNXREGENXBIO INC | $1.5B |
JNJJOHNSON & JOHNSON | $1.4B |
SLRNACELYRIN INC | $1.4B |
VRNAVERONA PHARMA PLC | $1.4B |
PSTXUSDPOSEIDA THERAPEUTICS INC | $1.3B |
RPRXROYALTY PHARMA PLC | $1.3B |
CTNMCONTINEUM THERAPEUTICS INC | $1.2B |
ACOGALPHA COGNITION INC | $1.2B |
GONGERON CORP | $1.2B |
LXEOLEXEO THERAPEUTICS INC | $1.1B |
AKROAKERO THERAPEUTICS INC | $1.1B |
LLYELI LILLY & CO | $1.0B |
IBIOIBIO INC | $1.0B |
5E7ITEOS THERAPEUTICS INC | $1.0B |
KZRKEZAR LIFE SCIENCES INC | $990.6M |
OABIOMNIAB INC | $984.5M |
REGNREGENERON PHARMACEUTICALS | $969.5M |
GPCRSTRUCTURE THERAPEUTICS INC | $957.9M |
BEAMBEAM THERAPEUTICS INC | $950.1M |
MLTXMOONLAKE IMMUNOTHERAPEUTICS | $943.5M |
PFEPFIZER INC | $929.9M |
FULCFULCRUM THERAPEUTICS INC | $922.4M |
DHRDANAHER CORPORATION | $918.2M |
DNLIDENALI THERAPEUTICS INC | $913.6M |
SRRKSCHOLAR ROCK HLDG CORP | $843.0M |
ANSCAGRICULTURE & NAT SOL ACQ CO | $843.0M |
SPROSPERO THERAPEUTICS INC | $825.3M |
KVACKEEN VISION ACQUISITION CORP | $824.3M |
CATBUSDASTRIA THERAPEUTICS INC | $813.4M |
NMRANEUMORA THERAPEUTICS INC. | $727.2M |
VYGRVOYAGER THERAPEUTICS INC | $718.9M |
BIOABIOAGE LABS INC | $712.4M |
ALECALECTOR INC | $696.1M |
ALNYALNYLAM PHARMACEUTICALS INC | $682.4M |
—INDIVIOR PLC | $671.9M |
DAWNDAY ONE BIOPHARMACEUTICALS I | $671.8M |
CDTXCIDARA THERAPEUTICS INC | $670.3M |
KPRXKIORA PHARMACEUTICALS INC | $660.7M |
Page 1 of 3Next